Literature DB >> 11119508

Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.

K Kawakami1, Y Kinjo, S Yara, Y Koguchi, K Uezu, T Nakayama, M Taniguchi, A Saito.   

Abstract

We examined the effect of alpha-galactosylceramide (alpha-GalCer) on the synthesis of gamma interferon (IFN-gamma) and local resistance in mice infected intravenously with Cryptococcus neoformans. The level of IFN-gamma in serum increased on day 3, reached a peak level on day 7, and decreased to the basal level on day 14 postinfection in mice treated with alpha-GalCer, while in vehicle-treated mice, no increase was detected at any time points except for a small increase on day 7. Such effects were not observed in NKT-KO mice. In CD4KO mice, minor synthesis of IFN-gamma was detected on day 3 in sera but was completely abolished by day 7. The alpha-GalCer-induced IFN-gamma production on day 3 was partially reduced in mice depleted of NK cells by treatment with anti-asialo-GM(1) antibody (Ab). Spleen cells obtained from infected and alpha-GalCer-treated mice on day 7 produced a large amount of IFN-gamma upon restimulation with live organisms, while only a marginal level of production was detected in splenocytes from infected and vehicle-treated mice. Such effects were abolished in CD4KO and NKT-KO mice. Finally, the fungal loads in the lungs and spleen on days 7 and 14 were significantly reduced in alpha-GalCer-treated mice compared to those in control mice. In NKT-KO mice, local resistance elicited by alpha-GalCer was completely abolished, although no obvious exacerbation of infection was detected. Furthermore, treatment with anti-IFN-gamma monoclonal Ab mostly abrogated the protective effect of this agent. Thus, our results indicated that activation of Valpha14(+) NKT cells resulted in an increased Th1 response and local resistance to C. neoformans through production of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119508      PMCID: PMC97874          DOI: 10.1128/IAI.69.1.213-220.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family.

Authors:  B J Fowlkes; A M Kruisbeek; H Ton-That; M A Weston; J E Coligan; R H Schwartz; D M Pardoll
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

2.  alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.

Authors:  G Gonzalez-Aseguinolaza; C de Oliveira; M Tomaska; S Hong; O Bruna-Romero; T Nakayama; M Taniguchi; A Bendelac; L Van Kaer; Y Koezuka; M Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.

Authors:  M A Mieza; T Itoh; J Q Cui; Y Makino; T Kawano; K Tsuchida; T Koike; T Shirai; H Yagita; A Matsuzawa; H Koseki; M Taniguchi
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

4.  Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.

Authors:  J C Guery; F Galbiati; S Smiroldo; L Adorini
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

5.  Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations.

Authors:  Y Makino; R Kanno; T Ito; K Higashino; M Taniguchi
Journal:  Int Immunol       Date:  1995-07       Impact factor: 4.823

Review 6.  Fungal infections in AIDS patients.

Authors:  D A Stevens
Journal:  Br J Clin Pract Suppl       Date:  1990-09

7.  Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.

Authors:  K Kawakami; M Hossain Qureshi; T Zhang; Y Koguchi; Q Xie; M Kurimoto; A Saito
Journal:  Cell Immunol       Date:  1999-10-10       Impact factor: 4.868

8.  Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production.

Authors:  T Yoshimoto; A Bendelac; C Watson; J Hu-Li; W E Paul
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

9.  Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.

Authors:  K Takeda; S Seki; K Ogasawara; R Anzai; W Hashimoto; K Sugiura; M Takahashi; M Satoh; K Kumagai
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.

Authors:  E Y Denkers; T Scharton-Kersten; S Barbieri; P Caspar; A Sher
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

Review 2.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.

Authors:  Isabel Sada-Ovalle; Markus Sköld; Tian Tian; Gurdyal S Besra; Samuel M Behar
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

Review 4.  Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Neal N Padte; Xiangming Li; Moriya Tsuji; Sandhya Vasan
Journal:  Clin Immunol       Date:  2010-12-24       Impact factor: 3.969

Review 5.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

6.  The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa.

Authors:  Michael T Borchers; Nathaniel L Harris; Scott C Wesselkamper; Shiping Zhang; Yi Chen; Lisa Young; Gee W Lau
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Therapeutic effect of repeated natural killer T cell stimulation in mouse cholangitis complicated by colitis.

Authors:  Yoshihiro Numata; Susuma Tazuma; Yoshitaka Ueno; Tomoji Nishioka; Hideyuki Hyogo; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

8.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

9.  Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells.

Authors:  Norihito Tarumoto; Yuki Kinjo; Naoki Kitano; Daisuke Sasai; Keigo Ueno; Akiko Okawara; Yuina Izawa; Minoru Shinozaki; Hiroshi Watarai; Masaru Taniguchi; Haruko Takeyama; Shigefumi Maesaki; Kazutoshi Shibuya; Yoshitsugu Miyazaki
Journal:  J Infect Dis       Date:  2013-10-04       Impact factor: 5.226

10.  Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.

Authors:  Rebecca Blackstock; Juneann W Murphy
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.